Home Tools
Log in
Cart

Search Result

Search Results for " vasoactive intestinal peptide "

Targets

22

Compounds

8

Recombinant Proteins

Cat No. Product Name Synonyms Targets
TP1016L Aviptadil Acetate Vasoactive Intestinal Peptide acetate salt RAAS , SARS-CoV
Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) induces pulmonary vasodilation and inhibits the proliferation of vascular SMCs and platelet aggregation. Avitadil acetate can be used for research on pulmona...
T80866 VIP(Guinea pig) TFA Vasoactive Intestinal Peptide, guinea pig TFA
Vasoactive Intestinal Peptide (VIP) Guinea pig TFA, a trophic and mitogenic factor, promotes growth in cultured whole embryos and acts as a gastrointestinal hormone, while also indicating potential neurotransmitter funct...
TP1016 Aviptadil Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine)
Aviptadil (INN) is an analog of vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction.
TP1627L Prepro VIP (111-122), human acetate Prepro VIP (111-122), human acetate(123025-94-5 free base) Others
Prepro VIP (111-122), human acetate is a prepro-vasoactive intestinal polypeptide (VIP)–derived peptide, corresponding to residues 111-122.
TP2103L [D-p-Cl-Phe6,Leu17]-VIP acetate Others
[D-p-Cl-Phe6,Leu17]-VIP acetate is a competitive and selective antagonist of vasoactive intestinal peptide (VIP) receptor (IC50 = 125.8 nM).
TP1283L VIP(6-28)(human, rat, porcine, bovine) acetate Others
VIP(6-28)(human, rat, porcine, bovine) acetate is an antagonist of the actions of exogenous vasoactive intestinal peptide (VIP) receptor on cAMP in the superior cervical ganglion (SCG).
TP1283 VIP(6-28)(human, rat, porcine, bovine)
VIP(6-28)(human, rat, porcine, bovine) is a potent antagonist that effectively counteracts the effects of exogenous vasoactive intestinal peptide (VIP) on cyclic adenosine monophosphate (cAMP) signaling.
T36635 [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) is an analog of GRF and a vasoactive intestinal peptide (VIP) antagonist.
TP1627 Prepro VIP (111-122), human
Prepro VIP (111-122), human is a prepro-vasoactive intestinal polypeptide (VIP)–derived peptide, corresponding to residues 111-122.
TP2103 [D-p-Cl-Phe6,Leu17]-VIP
Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50 = 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors.
TP1635 Prepro VIP (81-122), human
Prepro VIP (81-122), human is a prepro-vasoactive intestinal polypeptide (VIP) derived peptide, corresponding to residues 81-122.
TP1054 PACAP (1-38), human, ovine, rat TFA Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA)
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP...
T83195 Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP(1-7)-GRF(8-27) is a selective antagonist [1] for the vasoactive intestinal peptide 1 (VIP 1) receptor.
T36428 PACAP-related Peptide (human) (trifluoroacetate salt) PACAP
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adeny...
T80876 Vasomera
Vasomera, a stable, long-acting vasoactive intestinal peptide (VIP) agonist, targets G-protein-coupled VPAC2 receptors and is employed in the study of cardiomyopathy associated with dystrophinopathies [1].
T78003 [D-p-Cl-Phe6,Leu17]-VIP TFA
[D-p-Cl-Phe6,Leu17]-VIP TFA acts as a competitive and selective antagonist of the vasoactive intestinal peptide (VIP) receptor, exhibiting an IC50 of 125.8 nM. It shows no activity on glucagon, secretin, or growth hormon...
T80069 PACAP (6-27) (human, ovine, rat) Pituitary adenylate cyclase-activating peptide (6-27)
PACAP (6-27) (human, ovine, rat) serves as an antagonist for the PACAP receptor, inhibiting the catecholamine response of the canine adrenal gland to vasoactive intestinal peptide (VIP). This compound holds promise for r...
T82217 Helospectin I
Helospectin I, a neuropeptide belonging to the vasoactive intestinal peptide (VIP) family, exhibits vasodilatory and antihypertensive properties, effectively reducing blood pressure. It was initially isolated from the sa...
T82216 Helospectin II
Helospectin II, a member of the vasoactive intestinal peptide (VIP) family, exhibits vasodilatory and antihypertensive properties that reduce blood pressure. This neuropeptide was initially isolated from the venom of the...
T81571 PACAP (1-38) free acid TFA
PACAP (1-38) free acid TFA, an endogenous neuropeptide, effectively enhances antral motility and somatostatin secretion, while concurrently suppressing gastrin secretion and promoting the release of vasoactive intestinal...
T78035 [K15,R16,L27]VIP(1-7)/GRF(8-27) acetate
[K15,R16,L27]VIP(1-7)/GRF(8-27) (acetate) is an acetate salt form of the peptide [K15,R16,L27]VIP(1-7)/GRF(8-27). This compound acts as a selective agonist for the VIP 1 receptor, displaying IC50 values of 2 nM for human...
T81572 PACAP (1-38) free acid
PACAP (1-38) free acid, an endogenous neuropeptide, potently modulates gastrointestinal and neuroendocrine functions. It enhances antral motility, increases somatostatin secretion, and stimulates the release of vasoactiv...

Compounds

Aviptadil Acetate
TP1016L
Synonym: Vasoactive Intestinal Peptide acetate salt
Target: RAAS, SARS-CoV
VIP(Guinea pig) TFA
T80866
Synonym: Vasoactive Intestinal Peptide, guinea pig TFA
Target:
Aviptadil
TP1016
Synonym: Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine)
Target:
Prepro VIP (111-122), human acetate
TP1627L
Synonym: Prepro VIP (111-122), human acetate(123025-94-5 free base)
Target: Others
[D-p-Cl-Phe6,Leu17]-VIP acetate
TP2103L
Synonym:
Target: Others
VIP(6-28)(human, rat, porcine, bovine) acetate
TP1283L
Synonym:
Target: Others
VIP(6-28)(human, rat, porcine, bovine)
TP1283
Synonym:
Target:
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
T36635
Synonym: [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
Target:
Prepro VIP (111-122), human
TP1627
Synonym:
Target:
[D-p-Cl-Phe6,Leu17]-VIP
TP2103
Synonym:
Target:
Prepro VIP (81-122), human
TP1635
Synonym:
Target:
PACAP (1-38), human, ovine, rat TFA
TP1054
Synonym: Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA)
Target:
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
T83195
Synonym:
Target:
PACAP-related Peptide (human) (trifluoroacetate salt)
T36428
Synonym:
Target: PACAP
Vasomera
T80876
Synonym:
Target:
[D-p-Cl-Phe6,Leu17]-VIP TFA
T78003
Synonym:
Target:
PACAP (6-27) (human, ovine, rat)
T80069
Synonym: Pituitary adenylate cyclase-activating peptide (6-27)
Target:
Helospectin I
T82217
Synonym:
Target:
Helospectin II
T82216
Synonym:
Target:
PACAP (1-38) free acid TFA
T81571
Synonym:
Target:
[K15,R16,L27]VIP(1-7)/GRF(8-27) acetate
T78035
Synonym:
Target:
PACAP (1-38) free acid
T81572
Synonym:
Target:

Recombinant Proteins

Cat No. Product Name Species Expression System
TMPY-03597 VIP Protein, Human, Recombinant (His) Human HEK293 Cells
VIP, or vasoactive intestinal peptide, is a neuropeptide of 28 amino acid residues that belongs to a glucagon/secretin superfamily, and it exerts its actions through three G-protein-coupled receptors (PAC1, VPAC1, and VP...
TMPY-01120 VPAC2 Protein, Human, Recombinant (mFc) Human HEK293 Cells
VIP and PACAP receptor 2, or VIPR2 encodes the VPAC2 receptor, which binds both VIP and PACAP. VPAC2 is expressed throughout the central nervous system and the periphery. Mutations in the VIPR2 homolog in the mouse cause...
TMPK-01505 HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated Human HEK293 Cells
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KD...
TMPK-01492 HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi) Human HEK293 Cells
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity i...
TMPK-01501 HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi) Human HEK293 Cells
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity i...
TMPK-01491 HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi), Biotinylated Human HEK293 Cells
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity i...
TMPK-01506 HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi) Human HEK293 Cells
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KD...
TMPK-01504 HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi) Human HEK293 Cells
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KD...
TargetMol